Cytek Biosciences Inc (CTKB)

$4.48 -0.03 (-0.67%)
Market Cap 554.93M
Revenue (ttm) 201.49M
Net Income (ttm) -66.54M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -33.02%
Debt to Equity Ratio 0.00
Volume 1,895,100
Avg Vol 865,942
Day's Range N/A - N/A
Shares Out 127.87M
Stochastic %K 83%
Beta 1.31
Analysts Sell
Price Target $6.00

Company Profile

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cyt...

Industry: Medical Devices
Sector: Healthcare
Phone: 877 922 9835
Address:
47215 Lakeview Blvd, Fremont, United States
FormerDemocrat
FormerDemocrat Mar. 16 at 8:13 PM
$CTKB mara
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 26 at 9:32 PM
$CTKB Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.34 down -585.71% YoY • Reported revenue of $62.14M up 8.12% YoY • Cytek Biosciences initiates its 2026 revenue guidance for full year 2026 revenue to be in the range of $205M to $212M, representing growth of 2% to 5% over full year 2025.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 26 at 3:17 AM
$CTKB RSI: 28.12, MACD: -0.2135 Vol: 0.34, MA20: 4.55, MA50: 4.95 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
RhoRevolution
RhoRevolution Feb. 4 at 3:51 PM
$CTKB is a medical device company (Cytek Biosciences) providing cell analysis systems; its growth is tied to research funding in immunology and cell biology.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 3 at 6:06 PM
$CTKB Current Stock Price: $5.02 Contracts to trade: $5.0 CTKB Feb 20 2026 Call Entry: $1.82 Exit: $3.36 ROI: 85% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 22 at 5:30 PM
$CTKB Share Price: $5.70 Contract Selected: Jul 17, 2026 $5 Calls Buy Zone: $1.47 – $1.81 Target Zone: $2.51 – $3.06 Potential Upside: 61% ROI Time to Expiration: 175 Days | Updates via https://fxcapta.com/stockinfo/
1 · Reply
kubota2323
kubota2323 Jan. 21 at 2:33 PM
$CTKB added/adding
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 14 at 12:51 AM
$CTKB RSI: 70.27, MACD: 0.1745 Vol: 0.32, MA20: 5.14, MA50: 5.06 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
DARKP00L
DARKP00L Jan. 12 at 10:14 AM
$CTKB 05:08 on Jan. 12 2026 Cytek Sees $62M Q4 Revenue, Forecasts About $201M in Full-Year 2025 Sales #tradeideas
0 · Reply
Phoenix2023
Phoenix2023 Jan. 2 at 4:25 PM
$CTKB Surprised there is not more interest in this company. So few watchers.
1 · Reply
Latest News on CTKB
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact

Mar 9, 2026, 5:00 PM EDT - 12 days ago

Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact

Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript

Feb 26, 2026, 8:57 PM EST - 22 days ago

Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript

Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results  and Provides 2026 Outlook

Feb 26, 2026, 4:05 PM EST - 23 days ago

Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results  and Provides 2026 Outlook

Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care Conference

Feb 18, 2026, 4:05 PM EST - 4 weeks ago

Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care Conference

Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Feb 12, 2026, 4:05 PM EST - 5 weeks ago

Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 15, 2026, 1:45 AM EST - 2 months ago

Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results

Jan 12, 2026, 5:00 AM EST - 2 months ago

Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results

Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth

Nov 20, 2025, 5:49 AM EST - 4 months ago

Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth

TIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026

Nov 12, 2025, 5:00 PM EST - 4 months ago

TIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026

Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year

Nov 6, 2025, 5:00 PM EST - 4 months ago

Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year

Cytek Biosciences to Participate in Upcoming Investor Conferences

Nov 6, 2025, 4:05 PM EST - 4 months ago

Cytek Biosciences to Participate in Upcoming Investor Conferences

Cytek Biosciences, Inc. (CTKB) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 8:51 PM EST - 4 months ago

Cytek Biosciences, Inc. (CTKB) Q3 2025 Earnings Call Transcript

Cytek Biosciences Reports Third Quarter 2025 Financial Results

Nov 5, 2025, 4:05 PM EST - 4 months ago

Cytek Biosciences Reports Third Quarter 2025 Financial Results

Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry

Oct 29, 2025, 5:00 PM EDT - 5 months ago

Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry

Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025

Oct 22, 2025, 4:05 PM EDT - 5 months ago

Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025

Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth

Oct 15, 2025, 5:00 PM EDT - 5 months ago

Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth

Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q's Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control

Sep 17, 2025, 9:00 AM EDT - 6 months ago

Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q's Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control

Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA

Sep 10, 2025, 5:00 PM EDT - 6 months ago

Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA

Cytek Biosciences, Inc. (CTKB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 10, 2025, 12:57 PM EDT - 6 months ago

Cytek Biosciences, Inc. (CTKB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Cytek Biosciences, Inc. (CTKB) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:25 AM EDT - 8 months ago

Cytek Biosciences, Inc. (CTKB) Q2 2025 Earnings Call Transcript

Cytek Biosciences Reports Second Quarter 2025 Financial Results

Aug 6, 2025, 4:05 PM EDT - 8 months ago

Cytek Biosciences Reports Second Quarter 2025 Financial Results

Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer

May 29, 2025, 5:00 PM EDT - 10 months ago

Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer

Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference

May 28, 2025, 4:05 PM EDT - 10 months ago

Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference

Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript

May 11, 2025, 8:30 PM EDT - 11 months ago

Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript

Cytek Biosciences Reports First Quarter 2025 Financial Results

May 8, 2025, 4:05 PM EDT - 11 months ago

Cytek Biosciences Reports First Quarter 2025 Financial Results

Cytek Biosciences: With Growth, Low Debt, And A Positive Long-Term Outlook, Is It Undervalued?

May 5, 2025, 8:14 AM EDT - 11 months ago

Cytek Biosciences: With Growth, Low Debt, And A Positive Long-Term Outlook, Is It Undervalued?

Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025

Apr 29, 2025, 5:00 PM EDT - 11 months ago

Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025

Why Cytek Biosciences Should Beat Q1 Earnings Expectations

Apr 28, 2025, 8:15 AM EDT - 11 months ago

Why Cytek Biosciences Should Beat Q1 Earnings Expectations

Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025

Apr 24, 2025, 4:05 PM EDT - 11 months ago

Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025

Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System

Mar 18, 2025, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System

Cytek Biosciences, Inc. (CTKB) Q4 2024 Earnings Conference Call Transcript

Feb 28, 2025, 9:49 AM EST - 1 year ago

Cytek Biosciences, Inc. (CTKB) Q4 2024 Earnings Conference Call Transcript

Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook

Feb 27, 2025, 4:05 PM EST - 1 year ago

Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook

Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Feb 13, 2025, 4:05 PM EST - 1 year ago

Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Upgrading Cytek Biosciences Stock On An Upcoming Catalyst

Jan 9, 2025, 9:30 AM EST - 1 year ago

Upgrading Cytek Biosciences Stock On An Upcoming Catalyst

Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 2, 2025, 8:00 AM EST - 1 year ago

Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

Dec 30, 2024, 8:00 AM EST - 1 year ago

Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 20, 2024, 4:05 PM EST - 1 year ago

Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

Nov 19, 2024, 5:00 PM EST - 1 year ago

Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

Nov 7, 2024, 5:00 PM EST - 1 year ago

Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

Cytek Biosciences, Inc. (CTKB) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 8:26 PM EST - 1 year ago

Cytek Biosciences, Inc. (CTKB) Q3 2024 Earnings Call Transcript

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

Sep 18, 2024, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

Cytek Announces Resignation of Chief Operating Officer Chris Williams

Sep 12, 2024, 3:20 PM EDT - 1 year ago

Cytek Announces Resignation of Chief Operating Officer Chris Williams

Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

Aug 21, 2024, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

Cytek Biosciences, Inc. (CTKB) Q2 2024 Earnings Call Transcript

Aug 11, 2024, 4:25 AM EDT - 1 year ago

Cytek Biosciences, Inc. (CTKB) Q2 2024 Earnings Call Transcript

Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm

Jul 30, 2024, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm

Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference

May 30, 2024, 4:05 PM EDT - 1 year ago

Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference

1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China

May 28, 2024, 5:30 PM EDT - 1 year ago

1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China

Lab Instrument Industry Update - New Commercial Entrants

May 23, 2024, 9:17 AM EDT - 1 year ago

Lab Instrument Industry Update - New Commercial Entrants

AKYA BNGO DHR LAB MASS OMIC QGEN

Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

May 20, 2024, 5:30 PM EDT - 1 year ago

Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

Cytek Biosciences, Inc. (CTKB) Q1 2024 Earnings Call Transcript

May 12, 2024, 3:24 AM EDT - 2 years ago

Cytek Biosciences, Inc. (CTKB) Q1 2024 Earnings Call Transcript

FormerDemocrat
FormerDemocrat Mar. 16 at 8:13 PM
$CTKB mara
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 26 at 9:32 PM
$CTKB Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.34 down -585.71% YoY • Reported revenue of $62.14M up 8.12% YoY • Cytek Biosciences initiates its 2026 revenue guidance for full year 2026 revenue to be in the range of $205M to $212M, representing growth of 2% to 5% over full year 2025.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 26 at 3:17 AM
$CTKB RSI: 28.12, MACD: -0.2135 Vol: 0.34, MA20: 4.55, MA50: 4.95 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
RhoRevolution
RhoRevolution Feb. 4 at 3:51 PM
$CTKB is a medical device company (Cytek Biosciences) providing cell analysis systems; its growth is tied to research funding in immunology and cell biology.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 3 at 6:06 PM
$CTKB Current Stock Price: $5.02 Contracts to trade: $5.0 CTKB Feb 20 2026 Call Entry: $1.82 Exit: $3.36 ROI: 85% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 22 at 5:30 PM
$CTKB Share Price: $5.70 Contract Selected: Jul 17, 2026 $5 Calls Buy Zone: $1.47 – $1.81 Target Zone: $2.51 – $3.06 Potential Upside: 61% ROI Time to Expiration: 175 Days | Updates via https://fxcapta.com/stockinfo/
1 · Reply
kubota2323
kubota2323 Jan. 21 at 2:33 PM
$CTKB added/adding
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 14 at 12:51 AM
$CTKB RSI: 70.27, MACD: 0.1745 Vol: 0.32, MA20: 5.14, MA50: 5.06 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
DARKP00L
DARKP00L Jan. 12 at 10:14 AM
$CTKB 05:08 on Jan. 12 2026 Cytek Sees $62M Q4 Revenue, Forecasts About $201M in Full-Year 2025 Sales #tradeideas
0 · Reply
Phoenix2023
Phoenix2023 Jan. 2 at 4:25 PM
$CTKB Surprised there is not more interest in this company. So few watchers.
1 · Reply
TylerDurd3n
TylerDurd3n Dec. 30 at 9:29 AM
$CTKB Love this thing, waiting for takeoff!
0 · Reply
SigilShares
SigilShares Dec. 25 at 12:30 PM
$CTKB Market behavior suggests investors are rewarding credible delivery more than theoretical upside. Commercial adoption must become steadier to neutralize skepticism around sustainability. If milestones arrive on time, perception can shift faster than fundamentals. Catalysts help, but operating proof ultimately carries the most weight.
0 · Reply
fjtbnh
fjtbnh Dec. 18 at 5:39 AM
$CTKB
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 5 at 2:44 PM
$CTKB Share Price: $5.14 Contract Selected: Jul 17, 2026 $5 Calls Buy Zone: $1.95 – $2.41 Target Zone: $3.71 – $4.54 Potential Upside: 80% ROI Time to Expiration: 223 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
TylerDurd3n
TylerDurd3n Nov. 30 at 3:32 AM
$CTKB
0 · Reply
Beepboopscoop
Beepboopscoop Nov. 26 at 2:13 PM
$CTKB People are sleeping on this one.
1 · Reply
GSP
GSP Nov. 24 at 1:43 AM
$AMTM $CTKB $DVLT $NNOX $WMT
0 · Reply
KirRoyalTrader
KirRoyalTrader Nov. 23 at 9:48 PM
$CTKB
0 · Reply
BioTechHealthX
BioTechHealthX Nov. 18 at 4:05 AM
$CTKB Cytek Biosciences Inc. (CTKB) jumped 39% in just 30 days after being named to TIME’s 2026 America’s Growth Leaders list. With CTKB trading near $5.50 despite industry accolades, rising recurring revenue, and expanding global adoption, investors are asking whether the market is still undervaluing this full-spectrum cytometry powerhouse. https://biotechhealthx.com/biotech-news/cytek-bio-ctkb-surges-39-in-1-month-after-time-2026-recognition/
0 · Reply